LAG3 and sarcoma: High levels of tumour cell expression of LAG3, TIM3, and VTCN1 have been reported in multiple cancer types, including sarcoma, often in association with a worse clinical outcome, indicating an active role in promoting an immunosuppressive, tumour-promoting microenvironment [4,140,142,143].